|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 38/17 | |||
| A61K 38/19 | |||
| A61K 38/43 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 16/22 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 2101807 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07869456.9 |
| Date of filing the European patent application | 2007-12-18 | |
| (97) | Date of publication of the European application | 2009-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/088000 |
| Date | 2007-12-18 |
| (87) | Number | WO 2008/077077 |
| Date | 2008-06-26 |
| (30) | Number | Date | Country code |
| 870741 P | 2006-12-19 | US | |
| 870745 P | 2006-12-19 | US | |
| 877267 P | 2006-12-27 | US | |
| 919638 P | 2007-03-22 | US | |
| 958384 P | 2007-07-05 | US | |
| 989397 P | 2007-11-20 | US |
| (72) |
FERRARA, Napoleone, US
KORSISAARI, Nina, US
MASS, Robert D., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (54) | VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS |
| VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS |